Without any mechanical support, a person whose heart stops will lose consciousness in roughly ten to thirty seconds as oxygenated blood stops reaching the brain. Irreversible brain damage begins within minutes. But the question has a much more interesting answer than that grim timeline suggests, because modern medicine has found several ways to keep a person alive while the heart is either stopped, removed, or replaced entirely. Depending on the circumstances, people have survived hours, days, and even years without a functioning biological heart.
The First Seconds After the Heart Stops
When the heart ceases pumping, the brain is the first organ in serious trouble. Cortical electrical activity drops off within ten to thirty seconds of cardiac arrest, which is why people lose consciousness so quickly after the heart stops.
The brain’s extreme vulnerability comes down to its energy demands. It consumes a disproportionate share of the body’s oxygen relative to its size, and it has almost no ability to store that oxygen locally. Other organs have a bit more runway. The kidneys and liver can tolerate somewhat longer periods without blood flow, though they too begin to suffer within minutes. But the brain sets the clock: at normal body temperature, somewhere around four to six minutes without circulation is the rough threshold after which permanent neurological damage becomes increasingly likely, and beyond ten minutes the odds of meaningful recovery drop sharply.
This is why CPR exists. Chest compressions generate only a fraction of normal blood flow, but even that fraction can extend the window for the brain and other organs, buying time until the heart can be restarted or a machine can take over.
Surgery Without a Beating Heart
During certain cardiac surgeries, the heart is deliberately stopped or even physically removed from the chest. Surgeons rely on a cardiopulmonary bypass (CPB) machine, which takes over the job of both the heart and lungs, circulating and oxygenating the blood while the surgical team works. This is the most literal version of living without a heart: the organ is either not beating or not there at all, and a machine keeps you alive.
How long can this last safely? The traditional benchmark was around three hours, but a large study presented at the American Association for Thoracic Surgery found that a bypass time of 240 minutes (four hours) carries no statistically significant increase in 30-day mortality or major complications compared to three hours, across the full range of cardiac operations.1AATS Archives. Duration of Cardiopulmonary Bypass in the Modern Era: 240 is Now Safe Four hours is now considered a safe threshold.
That does not mean bypass is harmless at any length. Blood flowing over the foreign surfaces of the bypass circuit triggers an inflammatory response, and the longer the exposure, the more that response can affect recovery. A systematic review found that longer CPB times were associated with more days on a ventilator after surgery, likely because the inflammation hits the lungs particularly hard.2PubMed Central. Impact of Cardiopulmonary Bypass Time on Postoperative Duration of Mechanical Ventilation in Patients Undergoing Cardiovascular Surgeries The practical message for surgeons is to keep bypass time as short as the procedure allows while not rushing complex repairs.
In extremely complex operations, bypass times can stretch well beyond four hours. Surgeons accept the added risk when the alternative is worse. Some aortic arch repairs and multi-valve procedures routinely approach or exceed that mark, and patients still recover, though the postoperative course tends to be rougher.
Total Artificial Hearts
Cardiopulmonary bypass is a temporary bridge measured in hours. Total artificial hearts (TAHs) are designed to replace the heart entirely for days, weeks, months, or in some cases longer. The concept goes back further than most people realize. In 1957, researchers implanted the first TAH in an animal, which survived for about ninety minutes. The first human implant came in 1969. Then in 1982, a retired dentist named Barney Clark became the first person to receive a permanent artificial heart, the Jarvik-7, and lived for 112 days. The second recipient survived 620 days.3PubMed Central. Evolution of Artificial Hearts: An Overview and History
The most widely used TAH in recent decades has been the SynCardia, a pneumatic device that physically replaces both ventricles. It is mainly used as a bridge to keep patients alive until a donor heart becomes available. In a review of 193 SynCardia patients, about 37% were ultimately transplanted, and the vast majority of those were in high-urgency status at the time.4PubMed Central. Heart transplantation after SynCardia(®) total artificial heart implantation The device keeps people alive who would otherwise die within days, but the complications are serious: in a U.S. hospital cohort, about 29% of TAH patients died during their hospital stay, and acute kidney failure occurred in roughly 69% of cases.5PubMed Central. In-hospital complications associated with total artificial heart implantation in the United States between 2004 to 2011
Newer designs are pushing the technology forward. A pediatric continuous-flow TAH uses a double-ended centrifugal pump small enough for children, with embedded sensors that track the rotor’s position in real time to monitor how the device is performing inside the body.6PubMed Central. Pediatric continuous-flow total artificial heart with rotor axial position tracking technology Meanwhile, engineers are working on fully implantable systems with wireless power transfer, removing the need for the external drivelines that currently exit through the skin and create an ongoing infection risk.7PubMed. Beyond Continuous-Flow: The Next Wave of Fully Implantable LVADs and Total Artificial Hearts
Living for Years on a Pump
While total artificial hearts replace the heart entirely, left ventricular assist devices (LVADs) work alongside whatever function the patient’s failing heart still has. An LVAD is a small mechanical pump surgically attached to the heart that helps push blood from the left ventricle into the aorta. For many patients with advanced heart failure, an LVAD is implanted as a “destination therapy,” meaning it is the treatment, not a temporary bridge to transplant. These devices can keep people alive and functional for years.
A ten-year follow-up from Chile’s first LVAD program tracked nine patients and found that cumulative survival was about 78% at one and two years, and roughly 62% at five and ten years. Among the patients still alive at the end of the study, the average time living on the device was approximately 10.8 years, and none had required a device replacement due to mechanical failure. Three of the four surviving patients were in the best functional class, able to carry out normal daily activities, and none had opted to be listed for a heart transplant.8PubMed Central. Ten-year follow-up of the first left ventricular assist device implantation program in Chile: a case series
Those numbers reflect the best-case experience with carefully selected patients at a single center. Broader registry data paints a less rosy picture. Among more than 1,600 LVAD patients implanted as destination therapy in a large U.S. registry, about 30% had a poor outcome at one year, defined as either dying (about 22%) or surviving but with persistently poor quality of life (about 7%).9PubMed Central. Frequency of Poor Outcome (Death or Poor Quality of Life) After Left Ventricular Assist Device for Destination Therapy The gap between the two datasets reflects how much patient selection, surgical experience, and follow-up care matter.
LVADs are not without their own complications. Bleeding and stroke remain the most feared risks, driven partly by the blood-thinning medications patients must take to prevent clots from forming inside the pump. Infections around the driveline exit site are common. And the continuous-flow pumps used in most modern LVADs produce a steady stream of blood rather than a pulse, which means many LVAD patients have no detectable pulse at all. A paramedic checking for a pulse on an LVAD patient’s wrist would find nothing and might wrongly conclude the person is dead.
When Cold Buys Time
Temperature changes the math on how long a body can survive without a heartbeat. At normal body temperature, brain cells begin dying within minutes. But when the body is cold, metabolic activity slows dramatically, and the brain’s oxygen demands drop in proportion. This is why some drowning victims pulled from icy water after thirty, forty, or even sixty minutes without a heartbeat have been resuscitated with their brains intact.
The underlying mechanism is straightforward. Cold slows every chemical reaction in the body, including the cascades that kill brain cells during oxygen deprivation. Unlike cardiac arrest at normal temperature, where neuronal damage builds rapidly, progressive hypothermia markedly reduces the brain’s metabolic rate and oxygen consumption, delaying the energy depletion and toxic chemical buildup that cause cell death.10PubMed Central. Extracorporeal Life Support in Severe Accidental Hypothermia: Mechanisms, Challenges and Clinical Horizons Prolonged periods without blood flow can therefore be compatible with neurological recovery when effective rewarming and reperfusion are eventually achieved.
Case reports bear this out. A study of survivors of accidental deep hypothermia and circulatory arrest, treated with extracorporeal blood rewarming, found that at follow-up there were no hypothermia-related problems that impaired quality of life. Neurological deficits observed in the early period after rewarming had fully or almost completely disappeared.11PubMed. Outcome of survivors of accidental deep hypothermia and circulatory arrest treated with extracorporeal blood warming In another case, a patient with prolonged hypothermic cardiac arrest was successfully resuscitated using only CPR and conventional rewarming, without the use of an extracorporeal bypass machine, and achieved a favorable neurological outcome even after several hours of cardiac arrest.12PubMed Central. Successful resuscitation from prolonged hypothermic cardiac arrest without extracorporeal life support
Surgeons exploit this principle deliberately during certain operations. Deep hypothermic circulatory arrest, or DHCA, has been used for over fifty years in the repair of complex congenital heart defects and aortic arch operations. The patient’s body temperature is lowered to around 18-20°C (roughly 64-68°F), at which point the bypass machine and the heart can be turned off entirely, giving the surgeon a bloodless, motionless field to work in.13PubMed. Neonatal brain protection and deep hypothermic circulatory arrest: pathophysiology of ischemic neuronal injury and protective strategies The brain tolerates this for roughly 30 to 45 minutes at deep hypothermia, sometimes longer. Researchers have even investigated whether proteins found in hibernating animals could extend this window; a study injected a protein isolated from hibernating chipmunks into rats before inducing deep hypothermic circulatory arrest and found that the protein had a significant neuroprotective effect, reducing inflammation and improving neurological recovery.14PubMed. Protection of the rat brain from hypothermic circulatory arrest injury by a chipmunk protein That particular line of research is still in its early stages, but it illustrates how scientists are trying to push the boundaries of how long tissues can survive without circulation.
What People Report Experiencing During Cardiac Arrest
When the heart stops and the brain loses blood flow, you might expect the subjective experience to be simple nothingness. But a surprising number of cardiac arrest survivors report vivid, structured experiences during the period when they were clinically dead. These near-death experiences, or NDEs, have been documented extensively, and the research raises questions that neuroscience has not fully answered.
A scoping review of NDEs after cardiac arrest noted that increased gamma oscillations and functional connectivity have been observed on EEG recordings in the first five minutes after cardiac arrest, which could serve as a physiological correlate to the heightened consciousness and lucid thought processes that patients describe.15PubMed Central. Near-death experiences after cardiac arrest: a scoping review In other words, the dying brain appears to become transiently more organized, not less, at least in some measurable ways.
Other researchers have used functional MRI to study the brains of people who previously had NDEs. They found that bursts of synchronized gamma activity have been observed near death in both animal models and a human patient, suggesting highly organized brain activity compatible with conscious processing at the edge of death.16PubMed Central. Neural regions associated with memories of Recalled Experiences of Death Whether this organized activity actually produces the rich subjective experiences people report, or whether the experiences arise through some other process, remains an open and fiercely debated question.
A narrative review examining this issue directly argues that the evidence points to NDEs occurring during the period of unresponsiveness itself, not during the initial seconds of arrest or after CPR restarts blood flow. Cardiac arrest leads to the loss of cortical electrical activity within ten to thirty seconds, and during CPR, brain electrical activity may remain absent or severely disturbed. If NDEs do occur during this period, that raises challenging questions about how consciousness can persist when measurable brain function is minimal.17PubMed. Near-death experience during cardiac arrest and consciousness beyond the brain The interpretation remains contentious. Some researchers view these experiences as evidence that consciousness can continue beyond measurable brain activity; others suspect the experiences are generated during brief windows of partial brain recovery that current monitoring simply does not capture well enough.
The Strange Psychology of Having No Heartbeat
For the people who live for months or years on a total artificial heart, the experience of surviving without a heartbeat raises questions that go beyond medicine and into philosophy. Your heartbeat has been with you since before you were born. It speeds up when you are afraid, pounds when you are in love, and quiets when you are calm. It is so deeply woven into your sense of self that losing it turns out to be psychologically disorienting in ways that even the patients themselves struggle to articulate.
Researchers who interviewed patients living with the Aeson total artificial heart found that while these patients presented well outwardly, in private conversations they described a bewildering existential disorientation centered on the absence of a heartbeat. The artificial heart generates an arterial pressure waveform that is indistinguishable from a natural heart’s, but it cannot recreate the heartbeat itself. Not just the audible thump, but the palpable sensation in the chest. Instead, patients hear the constant hum of a machine, operating at about a hundred beats per minute, completely unresponsive to their emotions. Anger, sadness, desire, fear: none of these alter its rhythm.18PubMed Central. The total artificial heart: An existential transformation beyond technology
The researchers noted something poignant: despite acknowledging that they carry a machine inside their chest, patients consistently referred to it as their “new heart” rather than a prosthetic device. That linguistic choice may be an act of acceptance or a subconscious reclamation of identity. It underscores how adaptable the human mind is, even when confronting a radical change to the most symbolically loaded organ in the body. The heart has carried metaphorical weight across virtually every human culture for thousands of years. Losing it and continuing to live is a situation our psychology was never built to process, and yet people find ways to do it.
ECMO and Emergency Bridge Support
Between the brief support of CPR and the permanence of an implanted device, there is a middle layer of technology called extracorporeal membrane oxygenation, or ECMO. An ECMO machine draws blood out of the body, oxygenates it, and pumps it back in, essentially doing the work of both the heart and lungs. It is used in intensive care when a patient’s heart or lungs have failed and need time to recover, or when a team is deciding whether a patient is a candidate for a transplant or a long-term device.
ECMO is not a long-term solution, but it can sustain life for days or even weeks. A study reviewing 370 ECMO patients found that five-year survival was about 33% for those on venoarterial ECMO (the type that supports the heart). Among patients who survived the first 30 days, the five-year survival rate jumped to 73%. Follow-up quality-of-life assessments showed that about 29% of survivors reported difficulty with daily activities, and roughly 23% had high post-traumatic stress scores. Despite the challenges, patients reported minimal regret that ECMO had been initiated.19PubMed. Long-term survival and quality of life after extracorporeal membrane oxygenation
The emotional and physical toll of ECMO is real, but the device occupies a crucial role in the chain of survival: it can keep someone alive while the medical team figures out the next step, whether that is heart recovery, transplant listing, or placement of a permanent device.
Pig Hearts and What Comes Next
The shortage of donor hearts is the reason all of this technology exists. There are far more people dying of heart failure than there are hearts available for transplant. Xenotransplantation, transplanting organs from genetically modified animals into humans, is one of the most watched areas of research because it could theoretically eliminate the shortage entirely.
Two human patients have now received genetically modified pig hearts under expanded-access authorization. They survived for 40 and 60 days, respectively, with the transplanted hearts failing before the patients died.20PubMed. Cardiac Xenotransplantation: Current State and Future Directions Those durations are modest, but the fact that a pig heart functioned inside a human body at all for weeks represents a step that was considered science fiction not long ago. Advances in genetic engineering and immunosuppressive drugs have reignited interest in the field, and researchers are openly discussing pig hearts as a potential future solution to the donor shortage.21PubMed. After the First Pig-to-Human Heart Transplant, Scientists Look to the Future of Cardiac Xenotransplantation
Meanwhile, researchers working on organ preservation are pushing the boundaries from the other direction. In an animal study, pig hearts were harvested 24 hours after brain death, then preserved for an additional 24 hours before being transplanted into recipient pigs. All transplanted animals remained stable throughout a 24-hour observation period, with normal blood pressure and kidney function. The hearts even responded appropriately to adrenaline testing, with blood pressure and heart rate increasing in a dose-dependent manner.22Scandinavian Cardiovascular Journal. Safe orthotopic transplantation of hearts harvested 24 hours after brain death and preserved for 24 hours If those preservation windows can be extended further and translated to human organs, it would dramatically expand the pool of usable donor hearts and reduce the desperate time pressure that currently defines heart transplantation.
The convergence of these technologies paints an unusual picture of the future. Between fully implantable artificial hearts with wireless charging, genetically engineered animal organs, and extended preservation techniques, the question of how long you can live without a heart is becoming less about biology and more about engineering. The heart was once the organ that defined life and death. Increasingly, it is becoming the organ that machines and modified animals can stand in for, while the person inside keeps living.